Abstract

The objectives of the current study were conducting a statistical study to find out the number of men with primary and secondary infertility, immune infertility, and unexplained infertility in the city of Tikrit. Isolation and identification of Gram-positive and Gram-negative aerobic bacteria, and the study of some patterns of sensitivity to antibiotics of the isolated bacteria. The results showed that the percentage of primary infertility was the highest among infertility diseases, as the percentage reached 57%, while the lowest percentage was for immunological infertility, as it amounted to 7%. While the percentage of secondary and unexplained infertility was 15% and 31%, respectively. About the bacteriological study, the results showed two types of isolates, single bacterial isolates (52%), mixed bacterial isolates (38%). Percentages of isolates from E. coli and Klebsiella spp. and Staphylococcus spp. and Streptococcus spp. were 100%, 12%, 18%, and 10%, respectively. E. coli showed total (100%) resistance to amoxicillin/clavulanic acid and ampicillin. 50% resistance to Nalidixic. Otherwise, Escherichia coli showed resistance of 40%, 20%, 60%, 20% and 50% to Imipenem, Amikacin, Gentamicin, Azithromycin and Cefepime respectively. Klebsiella showed total (100%) resistance to amoxicillin/clavulanic acid and ampicillin. 40% resistance to Nalidixic. Otherwise, Klebsiella spp. showed resistance of 20%, 10%, 10%, 40% and 20% to imipenem, amikacin, gentamicin, azithromycin and cefepime respectively. Staphylococcus aureus showed complete resistance to penicillin, oxacillin and cefoxitin. 10%, 0%, 30%, 30%, 0%, 90% and 50% are resistant to gentamicin, nitrofurantoin, erythromycin, azithromycin, rifampicin, trimethoprim and ciprofloxacin respectively. Streptococcus spp. completely resistant to penicillin, oxacillin and cefoxitin. 30%, 0%, 20%, 10%, 0%, 70% and 30% are resistant to gentamicin, nitrofurantoin, erythromycin, azithromycin, rifampicin, trimethoprim and ciprofloxacin respectively.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call